vs
安捷伦科技（A）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是Rollins, Inc.的2.0倍（$1.8B vs $906.4M），安捷伦科技净利率更高（17.0% vs 11.9%，领先5.1%），Rollins, Inc.同比增速更快（10.2% vs 7.0%），安捷伦科技自由现金流更多（$175.0M vs $111.2M），过去两年安捷伦科技的营收复合增速更高（6.9% vs 0.8%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
A vs ROL — 直观对比
营收规模更大
A
是对方的2.0倍
$906.4M
营收增速更快
ROL
高出3.2%
7.0%
净利率更高
A
高出5.1%
11.9%
自由现金流更多
A
多$63.8M
$111.2M
两年增速更快
A
近两年复合增速
0.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $906.4M |
| 净利润 | $305.0M | $107.8M |
| 毛利率 | 52.6% | — |
| 营业利润率 | 19.6% | 16.1% |
| 净利率 | 17.0% | 11.9% |
| 营收同比 | 7.0% | 10.2% |
| 净利润同比 | -4.1% | 2.5% |
| 每股收益（稀释后） | $1.07 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AROL
| Q1 26 | $1.8B | $906.4M | ||
| Q4 25 | $1.9B | $912.9M | ||
| Q3 25 | $1.7B | $1.0B | ||
| Q2 25 | $1.7B | $999.5M | ||
| Q1 25 | $1.7B | $822.5M | ||
| Q4 24 | $1.7B | $832.2M | ||
| Q3 24 | $1.6B | $916.3M | ||
| Q2 24 | $1.6B | $891.9M |
净利润AROL
| Q1 26 | $305.0M | $107.8M | ||
| Q4 25 | $434.0M | $116.4M | ||
| Q3 25 | $336.0M | $163.5M | ||
| Q2 25 | $215.0M | $141.5M | ||
| Q1 25 | $318.0M | $105.2M | ||
| Q4 24 | $351.0M | $105.7M | ||
| Q3 24 | $282.0M | $136.9M | ||
| Q2 24 | $308.0M | $129.4M |
毛利率AROL
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
营业利润率AROL
| Q1 26 | 19.6% | 16.1% | ||
| Q4 25 | 23.8% | 17.5% | ||
| Q3 25 | 20.7% | 21.9% | ||
| Q2 25 | 18.0% | 19.8% | ||
| Q1 25 | 22.4% | 17.3% | ||
| Q4 24 | 24.0% | 18.1% | ||
| Q3 24 | 21.1% | 20.9% | ||
| Q2 24 | 23.1% | 20.4% |
净利率AROL
| Q1 26 | 17.0% | 11.9% | ||
| Q4 25 | 23.3% | 12.8% | ||
| Q3 25 | 19.3% | 15.9% | ||
| Q2 25 | 12.9% | 14.2% | ||
| Q1 25 | 18.9% | 12.8% | ||
| Q4 24 | 20.6% | 12.7% | ||
| Q3 24 | 17.9% | 14.9% | ||
| Q2 24 | 19.6% | 14.5% |
每股收益（稀释后）AROL
| Q1 26 | $1.07 | $0.22 | ||
| Q4 25 | $1.53 | $0.24 | ||
| Q3 25 | $1.18 | $0.34 | ||
| Q2 25 | $0.75 | $0.29 | ||
| Q1 25 | $1.11 | $0.22 | ||
| Q4 24 | $1.23 | $0.22 | ||
| Q3 24 | $0.97 | $0.28 | ||
| Q2 24 | $1.05 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $116.5M |
| 总债务越低越好 | $3.0B | $650.6M |
| 股东权益账面价值 | $6.9B | $1.4B |
| 总资产 | $12.8B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资AROL
| Q1 26 | $1.8B | $116.5M | ||
| Q4 25 | $1.8B | $100.0M | ||
| Q3 25 | $1.5B | $127.4M | ||
| Q2 25 | $1.5B | $123.0M | ||
| Q1 25 | $1.5B | $201.2M | ||
| Q4 24 | $1.3B | $89.6M | ||
| Q3 24 | $1.8B | $95.3M | ||
| Q2 24 | $1.7B | $106.7M |
总债务AROL
| Q1 26 | $3.0B | $650.6M | ||
| Q4 25 | $3.0B | $486.1M | ||
| Q3 25 | $3.4B | $485.7M | ||
| Q2 25 | $3.3B | $485.3M | ||
| Q1 25 | $3.3B | $485.5M | ||
| Q4 24 | $3.3B | $395.3M | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
股东权益AROL
| Q1 26 | $6.9B | $1.4B | ||
| Q4 25 | $6.7B | $1.4B | ||
| Q3 25 | $6.4B | $1.5B | ||
| Q2 25 | $6.1B | $1.4B | ||
| Q1 25 | $6.0B | $1.4B | ||
| Q4 24 | $5.9B | $1.3B | ||
| Q3 24 | $5.9B | $1.3B | ||
| Q2 24 | $6.2B | $1.2B |
总资产AROL
| Q1 26 | $12.8B | $3.2B | ||
| Q4 25 | $12.7B | $3.1B | ||
| Q3 25 | $12.2B | $3.2B | ||
| Q2 25 | $12.2B | $3.2B | ||
| Q1 25 | $11.9B | $2.9B | ||
| Q4 24 | $11.8B | $2.8B | ||
| Q3 24 | $11.0B | $2.8B | ||
| Q2 24 | $10.9B | $2.8B |
负债/权益比AROL
| Q1 26 | 0.44× | 0.47× | ||
| Q4 25 | 0.45× | 0.35× | ||
| Q3 25 | 0.53× | 0.32× | ||
| Q2 25 | 0.55× | 0.34× | ||
| Q1 25 | 0.56× | 0.36× | ||
| Q4 24 | 0.57× | 0.30× | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $111.2M |
| 自由现金流率自由现金流/营收 | 9.7% | 12.3% |
| 资本支出强度资本支出/营收 | 5.2% | 0.8% |
| 现金转化率经营现金流/净利润 | 0.88× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $993.0M | $621.1M |
8季度趋势，按日历期对齐
经营现金流AROL
| Q1 26 | $268.0M | $118.4M | ||
| Q4 25 | $545.0M | $164.7M | ||
| Q3 25 | $362.0M | $191.3M | ||
| Q2 25 | $221.0M | $175.1M | ||
| Q1 25 | $431.0M | $146.9M | ||
| Q4 24 | $481.0M | $188.2M | ||
| Q3 24 | $452.0M | $146.9M | ||
| Q2 24 | $333.0M | $145.1M |
自由现金流AROL
| Q1 26 | $175.0M | $111.2M | ||
| Q4 25 | $452.0M | $159.0M | ||
| Q3 25 | $259.0M | $182.8M | ||
| Q2 25 | $107.0M | $168.0M | ||
| Q1 25 | $334.0M | $140.1M | ||
| Q4 24 | $388.0M | $184.0M | ||
| Q3 24 | $360.0M | $139.4M | ||
| Q2 24 | $230.0M | $136.4M |
自由现金流率AROL
| Q1 26 | 9.7% | 12.3% | ||
| Q4 25 | 24.3% | 17.4% | ||
| Q3 25 | 14.9% | 17.8% | ||
| Q2 25 | 6.4% | 16.8% | ||
| Q1 25 | 19.9% | 17.0% | ||
| Q4 24 | 22.8% | 22.1% | ||
| Q3 24 | 22.8% | 15.2% | ||
| Q2 24 | 14.6% | 15.3% |
资本支出强度AROL
| Q1 26 | 5.2% | 0.8% | ||
| Q4 25 | 5.0% | 0.6% | ||
| Q3 25 | 5.9% | 0.8% | ||
| Q2 25 | 6.8% | 0.7% | ||
| Q1 25 | 5.8% | 0.8% | ||
| Q4 24 | 5.5% | 0.5% | ||
| Q3 24 | 5.8% | 0.8% | ||
| Q2 24 | 6.5% | 1.0% |
现金转化率AROL
| Q1 26 | 0.88× | 1.10× | ||
| Q4 25 | 1.26× | 1.41× | ||
| Q3 25 | 1.08× | 1.17× | ||
| Q2 25 | 1.03× | 1.24× | ||
| Q1 25 | 1.36× | 1.40× | ||
| Q4 24 | 1.37× | 1.78× | ||
| Q3 24 | 1.60× | 1.07× | ||
| Q2 24 | 1.08× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ROL
暂无分部数据
